More importantly, TMEM16A has been demonstrated to be abnormally expressed in a variety of cancers, which could inhibit the invasion and metastasis of cancer cells and improve the prognosis of cancer (Jacobsen et al., 2013; Simon et al., 2013). This evidence concerns the gene ANO1 and cancer.